David O. Watson's Securities Transactions in Apellis Pharmaceuticals, Inc.

The filing details the securities transactions of David O. Watson, an officer at Apellis Pharmaceuticals, Inc. Watson has acquired a total of 5,000 shares of common stock through restricted stock vesting on January 16, 2025, and January 21, 2025. Additionally, Watson has sold 5,000 shares of common stock on three separate occasions in the past three months: July 16, 2025, August 18, 2025, and September 16, 2025, with gross proceeds totaling $358,450. The filing also indicates that Watson plans to sell another 5,000 shares on October 16, 2025, with an aggregate market value of $126,100. The transactions are part of a plan adopted on March 3, 2025.